201 related articles for article (PubMed ID: 28317482)
1. Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia.
Patti AM; Toth PP; Giglio RV; Banach M; Noto M; Nikolic D; Montalto G; Rizzo M
Curr Pharm Des; 2017; 23(17):2496-2503. PubMed ID: 28317482
[TBL] [Abstract][Full Text] [Related]
2. Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
Cicero AF; Colletti A
Phytomedicine; 2016 Oct; 23(11):1113-8. PubMed ID: 26621556
[TBL] [Abstract][Full Text] [Related]
3. The Role of Nutraceuticals in Statin Intolerant Patients.
Banach M; Patti AM; Giglio RV; Cicero AFG; Atanasov AG; Bajraktari G; Bruckert E; Descamps O; Djuric DM; Ezhov M; Fras Z; von Haehling S; Katsiki N; Langlois M; Latkovskis G; Mancini GBJ; Mikhailidis DP; Mitchenko O; Moriarty PM; Muntner P; Nikolic D; Panagiotakos DB; Paragh G; Paulweber B; Pella D; Pitsavos C; Reiner Ž; Rosano GMC; Rosenson RS; Rysz J; Sahebkar A; Serban MC; Vinereanu D; Vrablík M; Watts GF; Wong ND; Rizzo M;
J Am Coll Cardiol; 2018 Jul; 72(1):96-118. PubMed ID: 29957236
[TBL] [Abstract][Full Text] [Related]
4. Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Cicero AFG; Fogacci F; Stoian AP; Vrablik M; Al Rasadi K; Banach M; Toth PP; Rizzo M
Curr Atheroscler Rep; 2021 Aug; 23(10):57. PubMed ID: 34345932
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of Nutraceuticals with Lipid Lowering Properties.
Poli A; Visioli F
High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):113-118. PubMed ID: 30877602
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering nutraceuticals update on scientific evidence.
Derosa G; Colletti A; Maffioli P; D'Angelo A; Lupi A; Zito GB; Mureddu GF; Raddino R; Fedele F; Cicero AFG
J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):845-859. PubMed ID: 32639326
[TBL] [Abstract][Full Text] [Related]
7. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.
Aguiar C; Alegria E; Bonadonna RC; Catapano AL; Cosentino F; Elisaf M; Farnier M; Ferrières J; Filardi PP; Hancu N; Kayikcioglu M; Mello E Silva A; Millan J; Reiner Ž; Tokgozoglu L; Valensi P; Viigimaa M; Vrablik M; Zambon A; Zamorano JL; Ferrari R
Atheroscler Suppl; 2015 Sep; 19():1-12. PubMed ID: 26315511
[TBL] [Abstract][Full Text] [Related]
8. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.
Barrios V; Escobar C; Cicero AF; Burke D; Fasching P; Banach M; Bruckert E
Atheroscler Suppl; 2017 Feb; 24():1-15. PubMed ID: 27998714
[TBL] [Abstract][Full Text] [Related]
9. Short-Term Effect of Nutraceutical Fruit Juices on Lipid Metabolism in Patients with Acquired Hypercholesterolemia.
Ardissino D; Colletti A; Pellizzato M; Pagliari G; Di Pierro F; Cravotto G
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108520
[TBL] [Abstract][Full Text] [Related]
10. Comparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis.
Morze J; Osadnik T; Osadnik K; Lejawa M; Jakubiak G; Pawlas N; Gasior M; Schwingshackl L; Banach M
BMJ Open; 2020 Aug; 10(8):e032755. PubMed ID: 32819924
[TBL] [Abstract][Full Text] [Related]
11. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
12. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease.
Marazzi G; Pelliccia F; Campolongo G; Quattrino S; Cacciotti L; Volterrani M; Gaudio C; Rosano G
Am J Cardiol; 2015 Dec; 116(12):1798-801. PubMed ID: 26611120
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
15. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.
Gylling H; Plat J; Turley S; Ginsberg HN; Ellegård L; Jessup W; Jones PJ; Lütjohann D; Maerz W; Masana L; Silbernagel G; Staels B; Borén J; Catapano AL; De Backer G; Deanfield J; Descamps OS; Kovanen PT; Riccardi G; Tokgözoglu L; Chapman MJ;
Atherosclerosis; 2014 Feb; 232(2):346-60. PubMed ID: 24468148
[TBL] [Abstract][Full Text] [Related]
16. Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study.
Spigoni V; Aldigeri R; Antonini M; Micheli MM; Fantuzzi F; Fratter A; Pellizzato M; Derlindati E; Zavaroni I; Bonadonna RC; Dei Cas A
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704936
[TBL] [Abstract][Full Text] [Related]
17. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
18. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
